Biotransplant(BTRN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotransplant(BTRN)

BTRN 35.35

0.0%

Nov 10 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (1073)	11/1/2001 5:28:17 PM
From: Arthur Radley	Read Replies (1) of 1475

Appears that Biogen is moving back the date for Amevive to Q1-2003. This will allow MEDI/BTRN to cut the timeline for MEDI-507 submission and the headstart Biogen has currently. biz.yahoo.com Also it appears that MEDI will present at the CIBC conference in NYC on November 5th. This is normally a huge conference....so good exposure.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next